Genistein treatment increases bone mass in obese, hyperglycemic mice

Richard M Michelin,1 Layla Al-Nakkash,2 Tom L Broderick,3 Jeffrey H Plochocki4 1Arizona College of Osteopathic Medicine, 2Department of Physiology, 3Laboratory of Diabetes and Exercise Metabolism, Department of Physiology, 4Department of Anatomy, Arizona College of Osteopathic Medicine, Midwestern U...

Full description

Bibliographic Details
Main Authors: Michelin RM, Al-Nakkash L, Broderick TL, Plochocki JH
Format: Article
Language:English
Published: Dove Medical Press 2016-03-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/genistein-treatment-increases-bone-mass-in-obese-hyperglycemic-mice-peer-reviewed-article-DMSO
_version_ 1797935277943029760
author Michelin RM
Al-Nakkash L
Broderick TL
Plochocki JH
author_facet Michelin RM
Al-Nakkash L
Broderick TL
Plochocki JH
author_sort Michelin RM
collection DOAJ
description Richard M Michelin,1 Layla Al-Nakkash,2 Tom L Broderick,3 Jeffrey H Plochocki4 1Arizona College of Osteopathic Medicine, 2Department of Physiology, 3Laboratory of Diabetes and Exercise Metabolism, Department of Physiology, 4Department of Anatomy, Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ, USA Background: Obesity and type 2 diabetes mellitus are associated with elevated risk of limb bone fracture. Incidences of these conditions are on the rise worldwide. Genistein, a phytoestrogen, has been shown by several studies to demonstrate bone-protective properties and may improve bone health in obese type 2 diabetics. Methods: In this study, we test the effects of genistein treatment on limb bone and growth plate cartilage histomorphometry in obese, hyperglycemic ob/ob mice. Six-week-old ob/ob mice were divided into control and genistein-treated groups. Genistein-treated mice were fed a diet containing 600 mg genistein/kg for a period of 4 weeks. Cross-sectional geometric and histomorphometric analyses were conducted on tibias. Results: Genistein-treated mice remained obese and hyperglycemic. However, histomorphometric comparisons show that genistein-treated mice have greater tibial midshaft diameters and ratios of cortical bone to total tissue area than the controls. Genistein-treated mice also exhibit decreased growth plate thickness of the proximal tibia. Conclusion: Our results indicate that genistein treatment affects bone of the tibial midshaft in the ob/ob mouse, independent of improvements in the hyperglycemic state and body weight. Keywords: obesity, hyperglycemia, genistein, ob/ob mice, bone
first_indexed 2024-04-10T18:13:03Z
format Article
id doaj.art-cf34d402de0642e99c1d404633b304c0
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-04-10T18:13:03Z
publishDate 2016-03-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-cf34d402de0642e99c1d404633b304c02023-02-02T10:28:09ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072016-03-012016Issue 1637025990Genistein treatment increases bone mass in obese, hyperglycemic miceMichelin RMAl-Nakkash LBroderick TLPlochocki JHRichard M Michelin,1 Layla Al-Nakkash,2 Tom L Broderick,3 Jeffrey H Plochocki4 1Arizona College of Osteopathic Medicine, 2Department of Physiology, 3Laboratory of Diabetes and Exercise Metabolism, Department of Physiology, 4Department of Anatomy, Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ, USA Background: Obesity and type 2 diabetes mellitus are associated with elevated risk of limb bone fracture. Incidences of these conditions are on the rise worldwide. Genistein, a phytoestrogen, has been shown by several studies to demonstrate bone-protective properties and may improve bone health in obese type 2 diabetics. Methods: In this study, we test the effects of genistein treatment on limb bone and growth plate cartilage histomorphometry in obese, hyperglycemic ob/ob mice. Six-week-old ob/ob mice were divided into control and genistein-treated groups. Genistein-treated mice were fed a diet containing 600 mg genistein/kg for a period of 4 weeks. Cross-sectional geometric and histomorphometric analyses were conducted on tibias. Results: Genistein-treated mice remained obese and hyperglycemic. However, histomorphometric comparisons show that genistein-treated mice have greater tibial midshaft diameters and ratios of cortical bone to total tissue area than the controls. Genistein-treated mice also exhibit decreased growth plate thickness of the proximal tibia. Conclusion: Our results indicate that genistein treatment affects bone of the tibial midshaft in the ob/ob mouse, independent of improvements in the hyperglycemic state and body weight. Keywords: obesity, hyperglycemia, genistein, ob/ob mice, bonehttps://www.dovepress.com/genistein-treatment-increases-bone-mass-in-obese-hyperglycemic-mice-peer-reviewed-article-DMSOobesityhyperglycemiagenisteinob/ob micebone
spellingShingle Michelin RM
Al-Nakkash L
Broderick TL
Plochocki JH
Genistein treatment increases bone mass in obese, hyperglycemic mice
Diabetes, Metabolic Syndrome and Obesity
obesity
hyperglycemia
genistein
ob/ob mice
bone
title Genistein treatment increases bone mass in obese, hyperglycemic mice
title_full Genistein treatment increases bone mass in obese, hyperglycemic mice
title_fullStr Genistein treatment increases bone mass in obese, hyperglycemic mice
title_full_unstemmed Genistein treatment increases bone mass in obese, hyperglycemic mice
title_short Genistein treatment increases bone mass in obese, hyperglycemic mice
title_sort genistein treatment increases bone mass in obese hyperglycemic mice
topic obesity
hyperglycemia
genistein
ob/ob mice
bone
url https://www.dovepress.com/genistein-treatment-increases-bone-mass-in-obese-hyperglycemic-mice-peer-reviewed-article-DMSO
work_keys_str_mv AT michelinrm genisteintreatmentincreasesbonemassinobesehyperglycemicmice
AT alnakkashl genisteintreatmentincreasesbonemassinobesehyperglycemicmice
AT brodericktl genisteintreatmentincreasesbonemassinobesehyperglycemicmice
AT plochockijh genisteintreatmentincreasesbonemassinobesehyperglycemicmice